Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Paul Turnbull

- PMLiVE

Gilead’s triple HIV drug approval prompts GSK lawsuit

ViiV claims bictegravir infringes its patent estate

- PMLiVE

J&J takes option on Theravance’s JAK drug in $1bn deal

TD-1473 has potential treating ulcerative colitis, Crohn’s and IBD patients

- PMLiVE

W2O bolsters its commercialisation offering

Rita Glaze joins the firm as leader of value, pricing and market access practice

- PMLiVE

Narrative Health appoints a new director

Gillian Newbold joins the team from Healthcare Research Worldwide

It’s only money

Pricing and penalties

- PMLiVE

A Magical Makeover for Lucid Group

Lucid launch their new company branding

Lucid Group Communications Limited

Celgene building

Celgene’s triple multiple myeloma therapy clears phase III trial

The biotech says the combo hit its OPTIMISMM primary endpoint

- PMLiVE

Roche’s lung drug Esbriet reserved for worse cases, says NICE

Boehringer Ingelheim’s Ofev subject to same conditions

- PMLiVE

Smart watch epilepsy monitor cleared by FDA

Approval could potentially clear the way for insurers to reimburse its cost

- PMLiVE

Christian Pangratz to head up Sterna Biologicals

He joins as CEO having previously served as senior VP for Vectura Group

Juno Therapeutics names Cindy Elkins as CIO

She joins the biopharma from Genentech, where she was VP of IT

The secret of success

It is becoming clear that success in pharma is associated with specialisation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links